You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 64 No. 2, February 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (6)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Radiologic Imaging
 •Immunologic Disorders
 •Multiple Sclerosis/ Demyelinating Disease
 •Neurology, Other
 •Magnetic Resonance Imaging
 •Alert me on articles by topic

Determinants of Cerebral Atrophy Rate at the Time of Diagnosis of Multiple Sclerosis

Bas Jasperse, MD; Arjan Minneboo, MD; Vincent de Groot, MD; Nynke F. Kalkers, MD, PhD; Paul E. van Helden, MSc; Bernard M. J. Uitdehaag, MD, PhD; Frederik Barkhof, MD, PhD; Chris H. Polman, MD, PhD

Arch Neurol. 2007;64(2):190-194.

Objective  To identify determinants visible on magnetic resonance imaging of the brain that explain the subsequent rate of cerebral atrophy in patients with recently diagnosed multiple sclerosis.

Design  Magnetic resonance imaging of the brain was performed at baseline and after 2 years. T2 hyperintense lesion load, black hole lesion load, presence of contrast-enhancing lesions, and normalized brain volume were derived from the baseline magnetic resonance imaging and considered as possible explanatory variables for the subsequent annualized percentage of brain volume change (PBVC/y) using forward stepwise multiple linear regression analysis.

Setting  MS center Amsterdam, Department of Neurology, VU University Medical Center, Amsterdam, the Netherlands.

Patients  Eighty-nine patients recently diagnosed as having multiple sclerosis were included at the time of diagnosis from our outpatient clinic.

Main Outcome Measure  Annualized percentage of brain volume change.

Results  The mean (SD) annualized rate of cerebral atrophy was –0.9 (0.8) PBVC/y. Baseline normalized brain volume (standardized coefficient, 0.426; P = .001) and baseline T2 lesion load (standardized coefficient, –0.244; P = .02) were identified as explanatory variables for subsequent PBVC/y and yielded a regression model that explained 31.2% of the variance in PBVC/y.

Conclusions  In patients with recently diagnosed multiple sclerosis, the extent of accumulated brain tissue loss and overall lesion load partly explain the subsequent rate of cerebral atrophy.


Author Affiliations: Departments of Neurology (Drs Jasperse, Kalkers, Uitdehaag, and Polman), Radiology (Drs Minneboo and Barkhof and Mr van Helden), and Rehabilitation Medicine (Dr de Groot), VU University Medical Center, Amsterdam, the Netherlands.


RELATED ARTICLE

What Causes Multiple Sclerosis to Worsen?
J. Theodore Phillips
Arch Neurol. 2007;64(2):167-168.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing remitting experimental autoimmune encephalomyelitis
Rasmussen et al.
Brain 2007;130:2816-2829.
ABSTRACT | FULL TEXT  

What Causes Multiple Sclerosis to Worsen?
Phillips
Arch Neurol 2007;64:167-168.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.